019736 S31 M1 1571

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

3

Document text

BioNTech RNA Pharmaceuticals GmbH 07/10/2020
An der Goldgrube 12
Mainz N/A
Germany 55131215-280-5503
COVID-19 Vaccine (BNT162, PF-07302048) 019736
Prophylactic immunization against COVID-19 in adults 
18 years of age
0 0 3 0
3
FDA-CBER-2021 5683-1072441
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE 
Elisa Harkins, Global Regulatory Lead, Pfizer Global Regulatory Affairs - Vaccines
215-280-5503 (845) 474-3500
500 Arcola Road
 
Collegeville PA
United States of America [email protected]
07/09/2020
United States of America
Elisa Harkins TullDigitally signed by Elisa Harkins 
Tull 
Date: 2020.07.09 16:05:54 -04'00'
3
FDA-CBER-2021-5683-1072442
3
FDA-CBER-2021-5683-1072443